2022
DOI: 10.1557/s43578-022-00796-8
|View full text |Cite
|
Sign up to set email alerts
|

Understanding toxicity associated with boron nitride nanotubes: Review of toxicity studies, exposure assessment at manufacturing facilities, and read-across

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
11
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 14 publications
(12 citation statements)
references
References 98 publications
0
11
0
Order By: Relevance
“…In the present study, it is assumed that a single dose of 30 μg per mouse was representative of a worst-case scenario such as accidental exposure at a production facility with no respiratory protection. , Despite this high dose, low aspect ratio h -BN nanosheets did not cause any lung inflammation or damage and were eliminated efficiently from the lungs, with only a few materials remaining after 28 days. The absence of acute immune response was somewhat surprising because most of the 2D materials tested so far by us and others induced at least an acute lung inflammation after administration to high doses in rodents. ,, …”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…In the present study, it is assumed that a single dose of 30 μg per mouse was representative of a worst-case scenario such as accidental exposure at a production facility with no respiratory protection. , Despite this high dose, low aspect ratio h -BN nanosheets did not cause any lung inflammation or damage and were eliminated efficiently from the lungs, with only a few materials remaining after 28 days. The absence of acute immune response was somewhat surprising because most of the 2D materials tested so far by us and others induced at least an acute lung inflammation after administration to high doses in rodents. ,, …”
Section: Resultsmentioning
confidence: 99%
“…Overall, it remains unknown if BNNTs with a greater amount of nanotubes per mass could cause permanent lung damage at doses similar to those used in previous in vivo works 10,11 or at a lower doses representative of occupational exposure. 16 The safety profile of h-BN nanosheets remains also largely unknown due to the lack of in vivo studies. Recently, Lucherelli et al, investigated two types of h-BN nanosheets, one with a cornered/sharp structure and one with a round form, the latter similar to h-BN used in the present study.…”
Section: Introductionmentioning
confidence: 99%
“…Similarly, while boron nitride nanotubes exhibit enticing properties, the complexity of their synthesis and potential reactivity challenge their seamless incorporation into biomimetic environments. 20 Moreover, achieving biocompatibility for silica nanotubes through surface modification is feasible, but their nonbiodegradable characteristics pose safety concerns and act as a barrier to their advancement. 21 Cyclic peptide nanotubes (CPNTs) emerge as a recent addition to this discourse, bringing forth substantial promise.…”
Section: Introductionmentioning
confidence: 99%
“…Carbon nanotubes, celebrated for their unparalleled mechanical and electrical attributes, are hindered by biocompatibility concerns and potential toxicity limitations, which curtail their widespread biological application. Similarly, while boron nitride nanotubes exhibit enticing properties, the complexity of their synthesis and potential reactivity challenge their seamless incorporation into biomimetic environments . Moreover, achieving biocompatibility for silica nanotubes through surface modification is feasible, but their nonbiodegradable characteristics pose safety concerns and act as a barrier to their advancement …”
Section: Introductionmentioning
confidence: 99%
“…BNNTs have potential for self-cleaning and anticorrosive surfaces . Owing to BNNTs biological compatibility and reduced toxicity to cells compared to carbon nanotubes, there are many application arenas for BNNTs beyond the realm of industrial materials, including biological and clinical environments, such as in drug carrier design and cancer therapeutics . Despite the time since the first demonstration of BNNTs and their remarkable collection of properties, progress in their development has been slow.…”
Section: Introductionmentioning
confidence: 99%